Parameters for health risk assessment associated with chronic exposure to hydrogen sulphide in ambient air

View or download the full article: 
UDC: 
613; 614
Authors: 

P.Z. Shur1, K.V. Chetverkina1,2, А.А. Khasanova1

Organization: 

1Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya Str., Perm, 614045, Russian Federation
2Perm State Medical University Named After Academician E.A. Wagner, 26 Petropavlovskaya Str., Perm, 614000, Russian Federation, the Department of Public Health and Healthcare No. 2 with the course of health informatization

Abstract: 

High levels of chemical pollution in ambient air due to industrial emissions can facilitate development of functional disorders in various organs and systems. They are a significant component to be considered when assessing health risks under expo-sure to combined multi-factorial pollution. However, the issue of methodical approaches to assessing possible effects on health under exposure to combinations of chemicals has not been studied enough as regards public health risk assessment. Given that, we suggest a trend to develop the methodology that involves revising and substantiating indicators applied in health risk assessment. This should be done as new research data on influence exerted by chemicals on health (including exposure to levels higher than reference ones) become available.

We have substantiated a system of quantitative indicators (including additional reference concentrations) for health risk assessment under chronic exposure to hydrogen sulphide in ambient air (including its elevated levels). Points of departure and modifying factors were established by analyzing studies on effects produced on health by hydrogen sulphide. On their basis, we developed parameters for non-carcinogenic health risk assessment.

The reference concentration equaled 0.002 mg/m3 (the critical systems were respiratory organs and the nervous system). The additional reference concentration for risk assessment under elevated exposure to hydrogen sulphide was substantiated as equal 0.07 mg/m3 (impaired development being the critical system in the case).

The suggested system of quantitative indicators enhances and specifies parameters for health risk assessment. This makes it possible to perform more adequate assessment of health risks under combined exposure to chemicals in ambient air including those contained in levels higher than reference ones.

The suggested system of quantitative indicators was tested properly; as a result, the system was established to give an opportunity to obtain more comprehensive and accurate results of health risk assessment under combined exposure to chemical pollutants.

Keywords: 
health risk assessment, hydrogen sulphide, chronic exposure, the system of quantitative indicators, reference concentration, respiratory system, nervous system, development
Shur P.Z., Chetverkina K.V., Khasanova А.А. Parameters for health risk assessment associated with chronic exposure to hydrogen sulphide in ambient air. Health Risk Analysis, 2023, no. 1, pp. 27–35. DOI: 10.21668/health.risk/2023.1.03.eng
References: 
  1. Zdorovaya okruzhayushchaya sreda – zdorovye lyudi [Healthy environment – healthy people]. WHO, Regional Office for Europe. Available at: https://www.euro.who.int/__data/assets/pdf_file/0007/367189/eceh-rus.pdf (November 24, 2022) (in Russian).
  2. U.S. EPA. A Review of the Reference Dose and Reference Concentration Processes: Final report (EPA/630/P-02/002F). U.S. Environmental Protection Agency, Risk Assessment Forum. Washington, DC, USA, 2002, 192 p.
  3. Glotov A.V., Megrelishvili V.D., Mal'tsev S.N., Dobrykh S.V. Otsenka nekantserogennogo riska zdorov'yu naseleniya goroda Omska v svyazi s khimicheskim zagryazneniem atmosfernogo vozdukha [Assessment of non-carcinogenic risk to the population in Omsk caused by chemical pollution in ambient air]. Okruzhayushchaya sreda i zdorov'e. Innovatsionnye podkhody v reshenii mediko-biologicheskikh problem zdorov'ya naseleniya: materialy VII Vserossiiskoi nauchno-prakticheskoi konferentsii s mezhdunarodnym uchastiem molodykh uchenykh i spetsialistov, Moscow, 2018, pp. 67–77 (in Russian).
  4. Spolyar L.W. Three men overcome by hydrogen sulfide in starch plant. Ind. Health Mon., 1951, vol. 11, no 8, pp. 116–117.
  5. Osbern L.N., Crapo R.O. Dung lung: A report of toxic exposure to liquid manure. Ann. Intern. Med., 1981, vol. 95, no. 3, pp. 312–314. DOI: 10.7326/0003-4819-95-3-312
  6. Shivanthan M.C., Perera H., Jayasinghe S., Karunanayake P., Chang T., Ruwanpathirana S., Jayasinghe N., De Silva Y., Jayaweerabandara D. Hydrogen sulphide inhalational toxicity at a petroleum refinery in Sri Lanka: A case series of seven survivors following an industrial accident and a brief review of medical literature. J. Occup. Med. Toxicol., 2013, vol. 8, no. 1, pp. 9. DOI: 10.1186/1745-6673-8-9
  7. Shur P.Z., Zaitseva N.V., Khasanova А.А., Chetverkina К.V., Ukhabov V.М. Establishing indicators for as-sessing non-carcinogenic risks under chronic inhalation exposure to benzene and average annual MPC for benzene as per health risk criteria. Health Risk Analysis, 2021, no. 4, pp. 42–49. DOI: 10.21668/health.risk/2021.4.04.eng
  8. Toxicological profile for hydrogen sulfide and carbonyl sulfide. U.S. Department of Health and Human Services. Atlanta, 2016, 298 p.
  9. Toxicological profile for hydrogen sulfide. U.S. Department of Health and Human Services. Atlanta, 2006, 253 p.
  10. Concise International Chemical Assessment Document 53. Hydrogen sulfide: human health aspects. Geneva, WHO, 2003, 41 p.
  11. Glass D.C. A review of the health effects of hydrogen sulphide exposure. Ann. Occup. Hyg., 1990, vol. 34, no. 3, pp. 323–327. DOI: 10.1093/annhyg/34.3.323
  12. Hirsch A.R., Zavala G. Long term effects on the olfactory system of exposure to hydrogen sulfide. Occup. Environ. Med., 1999, vol. 56, no. 4, pp. 284–287. DOI: 10.1136/oem.56.4.284
  13. Brenneman K.A., James R.A., Gross E.A., Dorman D.C. Olfactory neuron loss in adult male CD rats following subchronic inhalation exposure to hydrogen sulfide. Toxicol. Pathol., 2000, vol. 28, no. 2, pp. 326–333. DOI: 10.1177/019262330002800213
  14. 90 day vapor inhalation toxicity study of hydrogen sulfide in Sprague-Dawley rats: report to the Chemical Industry Institute of Toxicology (CIIT Docket No. 32063). Research Triangle Park, North Carolina, USA.
  15. Nasal Tumors in Animals and Man. Vol. I. Anatomy, Physiology, and Epidemiology. In: G. Reznik, S.F. Stinson eds. Boca Raton, USA, CRC Press, 2017, 290 p.
  16. Schreider J.P. Nasal airway anatomy and inhalation deposition in experimental animals and people. Nasal Tumors in Animals and Man. Vol. III. Boca Raton, USA, CRC Press, 1983, 26 p.
  17. Toxicological review of hydrogen sulfide. In Support of Summary Information on the Integrated Risk Information System (IRIS) (EPA/635/R-03/005). U.S. Environmental Protection Agency. Washington, DC, 2003, 74 p.
  18. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry (EPA/600/8-90/066F). U.S. Environmental Protection Agency. Research Triangle Park, North Carolina, USA, 1994, 389 p.
  19. Morgan D.L., Little P.B., Herr D.W., Moser V.C., Collins B., Herbert R., Johnson G.A., Maronpot R.R. [et al.]. Neu-rotoxicity of carbonyl sulfide in F344 rats following inhalation exposure for up to 12 weeks. Toxicol. Appl. Pharmacol., 2004, vol. 200, no. 2, pp. 131–145. DOI: 10.1016/j.taap.2004.04.013
  20. Dorman D.C., Struve M.F., Gross E.A., Brenneman K.A. Respiratory tract toxicity of inhaled hydrogen sulfide in Fischer-344 rats, Sprague-Dawley rats, and B6C3F1 mice following subchronic (90-day) exposure. Toxicol. Appl. Pharmacol., 2004, vol. 198, no. 1, pp. 29–39. DOI: 10.1016/j.taap.2004.03.010
  21. Hayden L.J., Goeden H., Roth S.H. Growth and development in the rat during sub-chronic exposure to low levels of hydrogen sulfide. Toxicol. Ind. Health, 1990, vol. 6, no. 3–4, pp. 389–401. DOI: 10.1177/074823379000600303
  22. Skrajny B., Hannah R.S., Roth S.H. Low concentrations of hydrogen sulphide alter monoamine levels in the developing rat central nervous system. Can. J. Physiol. Pharmacol., 1992, vol. 70, no. 11, pp. 1515–1518. DOI: 10.1139/y92-215
Received: 
27.12.2022
Approved: 
06.02.2023
Accepted for publication: 
10.03.2023

You are here